白宫撤回Heidi Overton FDA负责人提名
STAT+: White House pulls nomination of Heidi Overton to lead FDA
白宫已撤回对Heidi Overton担任FDA负责人的提名,原因是担心她在参议院卫生委员会缺乏足够共和党支持。参议院委员会领袖Sen. Bill Cassidy在周二晚间表示Overton已取得足够票数可通过委员会确认,但他随后发帖称"白宫放弃了Dr. Overton的一条可行确认路径"。原计划委员会曾预期于周三就其提名进行投票。
![]()
![]()
Daniel covers the intersection of the health industry and the federal government. He reports on corporate influence in government, the health consequences of federal policies, and the politics of health care. Confidential tips can be sent on Signal at danielp.100.
WASHINGTON — The Trump administration is pulling its nominee to lead the Food and Drug Administration, Heidi Overton, according to a White House official and a source close to Overton.
The decision follows concerns that Overton, a preventive care doctor who served in the Trump White House, lacked sufficient support from Republicans on the Senate’s health panel, which had been expected to vote on her nomination Wednesday. However, late on Tuesday, the panel’s leader, Sen. Bill Cassidy (R-La.), said Overton had sufficient support to clear his committee and win confirmation.
“Tonight, the White House abandoned a viable confirmation path for Dr. Overton,” Cassidy said in a post on X.
STAT+ Exclusive Story
Already have an account? Log in

This article is exclusive to STAT+ subscribers
Unlock this article — plus daily intelligence on Capitol Hill and the life sciences industry — by subscribing to STAT+.
Already have an account? Log in
To read the rest of this story subscribe to STAT+.
来源:STAT 主站 · statnews.com